X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DISHMAN PHARMA TTK HEALTHCARE/
DISHMAN PHARMA
 
P/E (TTM) x 32.9 25.1 131.3% View Chart
P/BV x 6.1 3.3 181.3% View Chart
Dividend Yield % 0.5 0.7 72.1%  

Financials

 TTK HEALTHCARE   DISHMAN PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
DISHMAN PHARMA
Mar-16
TTK HEALTHCARE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs663374 177.2%   
Low Rs399129 309.5%   
Sales per share (Unadj.) Rs535.6197.8 270.8%  
Earnings per share (Unadj.) Rs15.921.2 75.2%  
Cash flow per share (Unadj.) Rs20.034.7 57.7%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.80.8 94.7%  
Book value per share (Unadj.) Rs137.6179.9 76.5%  
Shares outstanding (eoy) m7.7780.69 9.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 78.0%   
Avg P/E ratio x33.311.9 280.7%  
P/CF ratio (eoy) x26.57.2 366.0%  
Price / Book Value ratio x3.91.4 275.9%  
Dividend payout %25.19.4 266.0%   
Avg Mkt Cap Rs m4,12720,306 20.3%   
No. of employees `0001.70.8 206.0%   
Total wages/salary Rs m6075,355 11.3%   
Avg. sales/employee Rs Th2,436.719,252.7 12.7%   
Avg. wages/employee Rs Th355.26,459.5 5.5%   
Avg. net profit/employee Rs Th72.52,064.1 3.5%   
INCOME DATA
Net Sales Rs m4,16215,961 26.1%  
Other income Rs m61265 23.1%   
Total revenues Rs m4,22316,226 26.0%   
Gross profit Rs m1974,103 4.8%  
Depreciation Rs m321,091 2.9%   
Interest Rs m30944 3.2%   
Profit before tax Rs m1972,334 8.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73624 11.7%   
Profit after tax Rs m1241,711 7.2%  
Gross profit margin %4.725.7 18.4%  
Effective tax rate %37.026.7 138.5%   
Net profit margin %3.010.7 27.8%  
BALANCE SHEET DATA
Current assets Rs m1,62911,018 14.8%   
Current liabilities Rs m1,0589,517 11.1%   
Net working cap to sales %13.79.4 145.9%  
Current ratio x1.51.2 133.0%  
Inventory Days Days30110 27.0%  
Debtors Days Days3435 96.4%  
Net fixed assets Rs m55616,304 3.4%   
Share capital Rs m78161 48.1%   
"Free" reserves Rs m87812,907 6.8%   
Net worth Rs m1,06914,516 7.4%   
Long term debt Rs m1594,189 3.8%   
Total assets Rs m2,39929,805 8.1%  
Interest coverage x7.63.5 218.3%   
Debt to equity ratio x0.10.3 51.4%  
Sales to assets ratio x1.70.5 323.9%   
Return on assets %6.48.9 71.9%  
Return on equity %11.611.8 98.3%  
Return on capital %18.517.5 105.3%  
Exports to sales %0.824.8 3.2%   
Imports to sales %1.43.7 37.5%   
Exports (fob) Rs m333,956 0.8%   
Imports (cif) Rs m58596 9.8%   
Fx inflow Rs m334,952 0.7%   
Fx outflow Rs m63697 9.1%   
Net fx Rs m-304,255 -0.7%   
CASH FLOW
From Operations Rs m1272,786 4.5%  
From Investments Rs m-146-1,529 9.5%  
From Financial Activity Rs m22-941 -2.3%  
Net Cashflow Rs m3316 0.8%  

Share Holding

Indian Promoters % 65.4 61.4 106.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 3.7 100.0%  
FIIs % 5.2 12.7 40.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 22.1 116.7%  
Shareholders   12,723 46,261 27.5%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 19, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - PFIZER COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS